Hence then, the article about kintor pharma announces first patient dosing in phase iii clinical trial of proxalutamide for the treatment of hospitalized covid 19 patients in us was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US )
Last updated :
Also on site :
- Prof. Schlevogt’s Compass No. 57: Liquidating tomorrow – When states kill possibility, not persons
- ‘Treasonous’: Trump hits out at critics, warns Iran's nuke's could have destroyed Europe, Middle East
- Peru probes trafficking of citizens to fight for Russia in Ukraine